Header Logo

Duration of aromatase inhibitor use and long-term cardiovascular risk in breast cancer survivors.

Duration of aromatase inhibitor use and long-term cardiovascular risk in breast cancer survivors. JNCI Cancer Spectr. 2025 Jan 28.

View in: PubMed

© 2025 Kaiser Permanente